Hartol en es it fr

Hartol Brand names, Hartol Analogs

Hartol Brand Names Mixture

  • No information avaliable

Hartol Chemical_Formula


Hartol RX_link

No information avaliable

Hartol fda sheet

Hartol msds (material safety sheet)

Hartol Synthesis Reference

No information avaliable

Hartol Molecular Weight

309.469 g/mol

Hartol Melting Point

< 25 oC

Hartol H2O Solubility

Soluble as HCl salt

Hartol State


Hartol LogP


Hartol Dosage Forms

Tablets (oral, 1 mg)

Hartol Indication

Used for the symptomatic treatment of parkinsonism.

Hartol Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Hartol Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Hartol side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Hartol Patient Information

Hartol Organisms Affected

Humans and other mammals